UBA1 and myelodysplastic syndrome: Moreover, in a near future, these approaches will be used to study VEXAS-like disorders whose genetic background is not yet elucidated, to patients with atypical UBA1 mutations as recently reported33,34 and to extend these approaches to a larger cohort of MDS.